Structure-Based Discovery of Potent Small-Molecule modulator Targeting the PD-1/PD-L1 interaction

Linyi Zhong; Guangping Li; Cheng-su Wang; Haiqiong Guo; Yong Hu; Minghe Luo; Qin Ouyang; Ting Xu; Tao Wang; Ning Zhang; Yuanqiang Wang

doi:10.1039/d6nj00836d

January 1, 2026New Journal of Chemistry

Structure-Based Discovery of Potent Small-Molecule modulator Targeting the PD-1/PD-L1 interaction

View Full Paper

Ask AI

Bookmark

Share

Key Points

To identify small-molecule modulators that effectively inhibit the PD-1/PD-L1 interaction.
Used structure-based discovery techniques to identify potential small-molecule inhibitors.
Focused on the binding interactions between PD-1 and PD-L1.
Identified several small-molecule candidates demonstrating potent modulation of the PD-1/PD-L1 interaction.
These candidates showed promising activity in preclinical models.

Implication

Discovery of potent small-molecule inhibitors targeting PD-1/PD-L1 interaction suggests new cancer therapy options.

Abstract

The PD-1/PD-L1 immune checkpoint is a central regulator of T-cell activity and a clinically validated target in cancer immunotherapy. While antibody-based therapies have achieved remarkable success, discovering small-molecule inhibitors capable...

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Zhong et al. (2026) studied this question.

synapsesocial.com/papers/6a192dd1fab5b468c4416bd1 https://doi.org/10.1039/d6nj00836d

View Full Paper

Ask AI

Bookmark

Share

Structure-Based Discovery of Potent Small-Molecule modulator Targeting the PD-1/PD-L1 interaction

Key Points

Implication

Abstract

Discussion

Cite This Study

Structure-Based Discovery of Potent Small-Molecule modulator Targeting the PD-1/PD-L1 interaction

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading